Skip to content
healthcare.dev

PRAVASTATIN SODIUM

NDC 69097-792, PRAVASTATIN SODIUM, tablet, from CIPLA USA INC..

Product NDC
69097-792
Status
Listed
Labeler
CIPLA USA INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077987
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-792 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PRAVASTATIN SODIUM80 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
69097-792-056909707920590 TABLET in 1 BOTTLE (69097-792-05)
69097-792-1269097079212500 TABLET in 1 BOTTLE (69097-792-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/678dfe58-3200-4c3d-9718-365aa47d070f
  • NADAC price for package 69097079205

    GET /v1/drugs/nadac/69097079205
  • NADAC price for package 69097079212

    GET /v1/drugs/nadac/69097079212

Use it

Look up 69097-792 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-792 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-792. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.